Pfizer: Cheap Doesn't Mean Good (NYSE:PFE)

In a previous bearish thesis on Pfizer Inc. (NYSE: PFE ), I recommended selling PFE stock. And it proved to be the right call because since early June, the company has massively underperformedI am a highly experienced Chief Financial Officer (CFO) with a strong background in the oilfield and real estate industries. With over a decade of experience in finance, I have led numerous complex due diligence efforts and M&A transactions, both domestically and internationally.In recent years, I have developed a keen ...